Saxenda Now Approved Jun 16, 2015Sep 25, 2015 Brand: Saxenda (liraglutide), Injection Parent Company: Novo Nordisk Drug Type: Prescription Drug Category: Nutrition and Weight Loss Campaign: now-approved Targeting: Patients Patient Website: https://www.saxenda.com/ HCP Website: https://www.saxendapro.com/ Now Approved Now Approved (Complete Screenshot) Now Approved on Mobile Submitted by: OnceDailyPharma